Adamas Pharmaceuticals Inc. 

CA

  SEC # 1328143

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  5/24/05   —   First EDGAR Filing:  5/24/05   –   Last Filing:  2/14/22  (None in the Past Year) 

Possible Termination of Registration and/or Duty to File Reports per 12/6/21 Form 15

Business Address      On:  2/14/22       [ Map ]		Mailing Address      On:  2/14/22       [ Map ]
1900 Powell St., Suite 1000 Emeryville, California  94608 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 510-450-3554		Delaware, U.S.A.		12/31/yy		42-1560076		0001328143		001-36399

Industry Classification
GICS – Global Industry Classification Standard:        Sector     Health Care   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2022 SEC Office of Life Sciences

        

Management
Director   In   CA   Demski Martha J 2014-2021   CA   Ericson William W. 2014-2021   CA   MacPhee John A 2014-2021   CA   Mahoney David L 2014-2021   MA   Bigham Michael 2016-2021   CA   Dier Mardi 2017-2021   CA   Papapetropoulos Spyros 2020-2021   CA   Richo Anna 2020-2021   CA   McFarlane Neil F. 2021   CA   Lieberburg Ivan M 2014-2020   CA   Went Gregory T 2014-2019   MA   Booth Richard H 2014-2017 ↓List Pre-2017 Directors				Officer  Since  Most-Recent Title   In   CA   McFarlane Neil F. 2019 Chief Executive Officer 2021   CA   Shreedhar Vijay 2019 Chief Commercial Officer 2021   CA   Prentiss Christopher B 2017 Chief Financial Officer 2021   CA   Merriweather Alfred G 2017 Chief Financial Officer 2019   CA   Rhodes Jennifer J 2016 CBO, GC & Compliance Officer 2019   CA   Patni Rajiv 2015 Chief Medical Officer 2019   CA   Went Gregory T 2014 Chief Executive Officer 2019   FL   King Richard 2017 Chief Operating Officer 2018   CA   Dawson William J 2014 Chief Financial Officer 2017 ↓List Pre-2017 Officers

        

        

        

        

Securities
Market:  Symbol       (Prices)   Nasdaq:  ADMS   _________  Symbol source:  SEC  As of:  1/14/22 – Old		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2023:   00548A 00548A·10·6     Common — COM USD.001 ← ADMS 00548A·01·5     Options _________  Classes source:  Form 13F Filings that list Section 13(f) Securities